Therapeutic approaches for corneal neovascularization

被引:0
作者
Sepehr Feizi
Amir A. Azari
Sharareh Safapour
机构
[1] Shahid Beheshti University of Medical Sciences,Ophthalmic Research Center, Labbafinejad Medical Center
来源
Eye and Vision | / 4卷
关键词
Corneal neovascularization; Angiogenesis; Angiogenic therapies;
D O I
暂无
中图分类号
学科分类号
摘要
Angiogenesis refers to new blood vessels that originate from pre-existing vascular structures. Corneal neovascularization which can lead to compromised visual acuity occurs in a wide variety of corneal pathologies. A large subset of measures has been advocated to prevent and/or treat corneal neovascularization with varying degrees of success. These approaches include topical corticosteroid administration, laser treatment, cautery, and fine needle diathermy. Since the imbalance between proangiogenic agents and antiangiogenic agents primarily mediate the process of corneal neovascularization, recent therapies are intended to disrupt the different steps in the synthesis and actions of proangiogenic factors. These approaches, however, are only partially effective and may lead to several side effects. The aim of this article is to review the most relevant treatments for corneal neovascularization available so far.
引用
收藏
相关论文
共 525 条
  • [71] Jackson D(2006)Ranibizumab for treatment of neovascular age-related macular degeneration: a phase I/ II multicenter, controlled, multidose study Ophthalmology 113 633-115
  • [72] Cao J(2009)Therapeutic monoclonal antibodies in ophthalmology Prog Retin Eye Res 28 117-805
  • [73] Radziejewski C(2011)Anti-VEGF treatment of corneal neovascularization Ocul Surf 9 227-1382
  • [74] Klettner A(2010)Effect of subconjunctival and intraocular bevacizumab injections on corneal neovascularization in a mouse model Curr Eye Res 35 108-85
  • [75] Roider J(2009)Bevacizumab accelerates corneal wound healing by inhibiting TGF-beta2 expression in alkali-burned mouse cornea BMB Rep 42 800-66
  • [76] Goldman J(2009)Short- and long-term safety profile and efficacy of topical bevacizumab (Avastin) eye drops against corneal neovascularization Graefes Arch Clin Exp Ophthalmol 247 1375-213
  • [77] Rutkowski JM(2010)The different effects of early and late bevacizumab (Avastin) injection on inhibiting corneal neovascularization and conjunctivalization in rabbit limbal insufficiency Invest Ophthalmol Vis Sci. 51 6277-4659
  • [78] Shields JD(2011)Subconjunctival injection of bevacizumab in the treatment of corneal neovascularization associated with lipid deposition Cornea 30 60-e38
  • [79] Pasquier MC(2014)Comparison of the effects of subconjunctival and topical anti-VEGF therapy (bevacizumab) on experimental corneal neovascularization Arq Bras Oftalmol 77 209-1349
  • [80] Cui Y(2009)Bevacizumab application delays epithelial healing in rabbit cornea Invest Ophthalmol Vis Sci 50 4653-83